The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy
J Public Health (Oxf)
.
2016 Dec 2;38(4):782-792.
doi: 10.1093/pubmed/fdv168.
Authors
JinXiao Lian
1
,
Sarah M McGhee
1
,
Rita A Gangwani
2
,
Christina Ka Wai Chan
2
,
Cindy Lo Kuen Lam
3
,
Maurice Keng Hung Yap
4
,
David Sai Hung Wong
2
Affiliations
1
School of Public Health, The University of Hong Kong, Hong Kong.
2
Department of Ophthalmology, The University of Hong Kong, Hong Kong.
3
Department of Family Medicine and Primary Care, The University of Hong Kong, Hong Kong.
4
School of Optometry, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong.
PMID:
28158645
DOI:
10.1093/pubmed/fdv168
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Cost-Benefit Analysis
Diabetic Retinopathy / diagnosis*
Diabetic Retinopathy / economics*
Health Care Costs*
Humans
Mass Screening / economics*